ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Novo Nordisk is expanding the global rollout of its new weight loss pill. The Danish pharmaceutical company moves to distribute the oral medication across international markets, building on its existing portfolio of obesity treatments. The pill offers an alternative to injectable weight loss drugs.
Tap to vote and see what everyone thinks.
Summary by ByteBrief